Order of the Court (Fourth Chamber) of 25 November 2011.
Yeda Research and Development Company Ltd and Aventis Holdings Inc. v Comptroller General of Patents, Designs and Trade Marks.
Reference for a preliminary ruling: Court of Appeal (England & Wales) (Civil Division) - United Kingdom.
Article 104(3), first subparagraph, of the Rules of Procedure - Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Article 3 - Conditions for obtaining a certificate - Concept of a ‘product protected by a basic patent in force’ - Criteria - Marketing authorisation - Medicinal product placed on the market containing only one active ingredient whereas the patent claims a combination of active ingredients.
Reports of Cases
Links to the texts